TROP2 marks relapse-driving colorectal cancer cells and opens path to targeted treatment

Medical Xpress

TROP2 marks relapse-driving colorectal cancer cells and opens path to targeted treatment

이 뉴스, 어떠셨어요?

한 번의 탭으로 반응을 남겨요 · 로그인 불필요

A team led by researchers from the German Cancer Research Center (DKFZ) and the HI-STEM Stem Cell Institute has discovered a promising new approach to treating advanced colorectal cancer.

The study, published in Nature, identifies a key marker of particularly aggressive and treatment-resistant colorectal cancer cells. ...

전문 보기

TROP2 marks relapse-driving colorectal cancer cells and opens path to targeted treatment

이 뉴스, 어떠셨어요?

관련 뉴스

'science' 카테고리 뉴스

World's first synthetic cell with a complete life cycle could revolutionize biological engineering

NHS patients are being socially prescribed yoga—but is yoga ready to help them?

New bioelectronic microdevices enable remote cell stimulation using ultrasound

Medical Xpress의 다른 기사

Lived experience is often dismissed—but we should recognize it as a form of expertise

AI turns mouse movements into language-like tokens, uncovering autism-related social behavior patterns

AI can be a personal trainer in your pocket—but is it safe?